FDA warns of nationwide Adderall shortage

FDA has released a warning to millions about a nation-wide Adderall shortage

The FDA says they’re experiencing a nation-wide Adderall shortage, a drug predominately used to treat ADHD.

The FDA says manufacturers across America are unable to meet consumer demands, causing the production line to cripple.

There has been a steep uptick in people using the medication recently, leaving some medical experts wondering why.

Supplies will not return to normal until 2023 with the administration advising people to look for alternative therapies in the meantime.